Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.63 |
| ▸ | SLC9A1 | P19634 | 4/20 | 0.54 |
| ▸ | HTR2B | P41595 | 5/20 | 0.52 |
| ▸ | HTR7 | P34969 | 4/20 | 0.52 |
| ▸ | HTR3E | A5X5Y0 | 2/20 | 0.50 |
| ▸ | HTR3B | O95264 | 2/20 | 0.50 |
| ▸ | HTR3A | P46098 | 2/20 | 0.50 |
| ▸ | HTR3D | Q70Z44 | 2/20 | 0.50 |
| ▸ | HTR3C | Q8WXA8 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7830653 | 0.89 | SLC9A1 (0.58) | PARP1SLC9A1HTR2BHTR7 | |
| SCHEMBL12858884 | 0.87 | PARP1 (0.61) | PARP1HDAC8HDAC6SMN1; SMN2SCN2A | |
| SCHEMBL8802133 | 0.82 | SLC9A1 (0.51) | SLC9A1HTR2BHTR7 | |
| Hydrochloric Acid SCHEMBL8643344 | 0.80 | HTR2B (0.50) | SLC9A1HTR2BHTR7 | |
| SCHEMBL27726091 | 0.79 | CYP2A6 (0.51) | SLC9A1HTR2BHTR7 | |
| SCHEMBL13749055 | 0.79 | PARP1 (0.59) | PARP1HDAC8HDAC6SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL8504119 | 0.79 | SLC9A1 (0.50) | SLC9A1HTR2BHTR7 | |
| SCHEMBL10802915 | 0.79 | PARP1 (0.59) | PARP1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL13799999 | 0.78 | PARP1 (1.00) | PARP1HDAC8HDAC6SMN1; SMN2 | |
| SCHEMBL12798 | 0.78 | PARP1 (1.00) | PARP1HDAC8HDAC6SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110028746-A1 | METHOD FOR THE DECARBOXYLATIVE HYDROFORMYLATION OF ALPHA, BETA- UNSATURATED CARBOXYLIC ACIDS | BASF SE (DE) | 2011-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028746-A1 | METHOD FOR THE DECARBOXYLATIVE HYDROFORMYLATION OF ALPHA, BETA- UNSATURATED CARBOXYLIC ACIDS | PCCA, CBR3, CBR1 | PARP1 1968/4885SLC9A1 539/4885HTR2B 964/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.